n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, October 9th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Graphene 3D Lab, Inc. (GPHBF)

Agora Financial, OTC Markets, and Stockhouse reported on Graphene 3D Lab, Inc. (GPHBF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Graphene 3D Lab, Inc., by way of its wholly-owned subsidiary, Graphene Laboratories, Inc., develops, manufactures, and markets proprietary graphene-based nanocomposite materials for diverse types of 3D printing. This includes fused filament fabrication. Additionally, the Company engages in the manufacture and sale of graphene materials and nanocomposite enhanced polymers via Graphene Laboratories. Graphene is a single-layer of carbon atoms. Graphene is considered a wonder-material for its high strength, conductivity, as well as ultra-light-weight.

Listed on the OTCQB, Graphene 3D Lab is headquartered in Calverton, New York. The Company’s facility is also in Calverton. This facility is equipped with material processing and analytical equipment. The Company’s go-to-market product is Conductive Graphene Filament. Graphene 3D Lab has its Industrial Materials Division to commercialize graphene composite materials.

Graphene 3D Lab also engages in the design, manufacture, and marketing of 3D printers and related products for domestic and global customers. The Company centers on the development and commercialization of technologies, which improve the capabilities of 3D printing.

Its 3D printing division provides a suite of specialty fused fabrication filaments. Also, Graphene 3D Lab owns a new proprietary technology covering the preparation and separation of graphene's atomic layers.

Conductive Graphene Filament brings users the ability to 3D print circuitry and sensors for electronic applications. Graphene 3D Lab introduced a new functional magnetic filament to its product line in 2016. The new filament was developed by Graphene 3D. It enables printing of 3D projects with components that are attracted to magnetic fields. The Company said that the filament is ideal for producing sensors and mechanical actuators and motors by additive manufacturing.

Graphene 3D Lab announced earlier this year the commercial release of two new additions to the G6-Epoxy™ product line of advanced adhesive materials. This product line includes innovative carbon-silver adhesive materials that are built on technology, which has undergone development by its Industrial Division. The new epoxies are highly electrically conductive adhesives with a proprietary formula based on the combination of graphene and silver fillers and other additives.

The Company and AzTrong, Inc. (AzT) announced this past June the signing of a Memorandum of Understanding (MoU). This MoU outlines the terms of the Strategic Alliance Agreement to be executed forthcoming. The aim of the Alliance is to capitalize on Graphene 3D Lab’s extensive base of customers and wide-ranging Intellectual Property (IP) portfolio in the graphene sector.

AzT will contribute its large-scale manufacturing base with well-developed infrastructure in the U.S. and Taiwan. The desired outcome is cost-effective production of performance-improving graphene-based products with a focus on the energy storage, construction, automotive, and defense sectors.

Graphene 3D Lab has released the Graphene-HIPS 3D Printing Filament. Graphene-HIPS is a distinctly engineered and unique semi-flexible FDM 3D Printing material reinforced with graphene. The design of it is for high performance 3D printing. The FDM material exhibits first-rate interlayer adhesion, toughness, and premier impact resistance.

At the end of July 2017, Graphene 3D Lab announced that Mr. Roman Rabinovich was appointed to the Board of Directors, effective immediately. He serves as a Senior Director at FTI Consulting. Mr. Rabinovich has considerable experience in strategic development, transaction advisory, litigation support, and business restructuring engagements. His specialty is analysis of corporate finance and building optimal pricing strategies to improve sales growth.

Graphene 3D Lab, Inc. (GPHBF), closed Monday's trading session at $0.0858, even for the day. The average volume for the last 60 days is 23,206 and the stock's 52-week low/high is $0.068/$0.18.

Aerpio Pharmaceuticals, Inc. (ARPO)

OTC Markets, HotStockCafe, HighRisingStocks, Street Insider, OTC Stock Picks, and MarketWatch reported on Aerpio Pharmaceuticals, Inc. (ARPO), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A biopharmaceutical company, Aerpio Pharmaceuticals, Inc. centers on first-in-class treatments for ocular diseases. The Company’s lead compound is AKB‐9778. This is a small molecule activator of the Tie2 pathway. It is in clinical development for the treatment of non-proliferative diabetic retinopathy. Aerpio Pharmaceuticals has its headquarters in Cincinnati, Ohio.

At present, AKB-9778 is in a Phase 2b study (TIME-2b) for the treatment of non-proliferative diabetic retinopathy (NPDR). This is a disease that affects millions of people worldwide. Diabetic Retinopathy (DR) is a complication of diabetes caused by damage to blood vessels in the retina. AKB-9778 is undergoing development as a subcutaneous injection.

In addition, the Company’s second program in development builds on its unique approach to targeting the Tie2 pathway. ARP-1536 is a humanized monoclonal antibody. It works by binding the extracellular domain of VE-PTP, inhibiting its ability to interact with the Tie2 receptor. This prevents the inactivation of Tie2. It also promotes vascular stability.

ARP-1536 is in pre-clinical development. Aerpio Pharmaceuticals’ plan is to develop ARP-1536 in combination with anti-VEGF therapy for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME).

Furthermore, Aerpio’s AKB-4924 is in Phase 1 clinical development. The Company’s plan is to develop it as a once-daily, oral treatment for inflammatory bowel disease (IBD). AKB-4924 is an innovative small molecule inhibitor of prolyl-hydroxylase domain enzymes (PHDs).

PHDs are important regulators of hypoxia inducible factor-1 alpha (HIF-1 alpha) that, when dysregulated, has been shown to worsen inflammation and disrupt intestinal epithelial barrier function. Through inhibiting PHDs, AKB-4924 stabilizes HIF-1 alpha. This leads to resolution of inflammation and restoration of epithelial barrier function.

In August of this year, Aerpio Pharmaceuticals reported financial results for Q2 ended June 30, 2017. Q2 2017 financial highlights include research and development (R&D) expenses of $3.1 million for Q2 of 2017, versus $2.9 million for the same period the year prior.

General and administrative expenses were $2.4 million for Q2 of 2017, versus $1.5 million for the same period in 2016. As of June 30, 2017, cash and cash equivalents totaled $29.8 million.

Aerpio Pharmaceuticals, Inc. (ARPO), closed Monday's trading session at $6.30, even for the day, on 2,400 volume with 8 trades. The average volume for the last 60 days is 4,787 and the stock's 52-week low/high is $5.90/$6.75.

NexOptic Technology Corp. (NXOPF)

Stockhouse, InvestorsHub, Equedia, and MarketWatch reported on NexOptic Technology Corp. (NXOPF) and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NexOptic Technology Corp. has an option to acquire, in the aggregate, 100 percent of Spectrum Optix, Inc., a private corporation (Calgary, Alberta). Essentially, at this time, the Companies are working as a single corporation; with their respective Chief Executive Officers (CEOs) sitting on each other's Boards of Directors. Spectrum Optix is developing technologies relating to imagery and light concentration applications. NexOptic Technology lists on the OTC Markets Group’s OTCQB. The Company is based in Vancouver, British Columbia.

Employing Blade Optics™, Spectrum Optix’s set of patent-pending optical technologies, Spectrum aims to increase aperture sizes within given depth constraints of various imaging and non-imaging optical applications. The two Companies believe that Blade Optics™ has the potential to breakdown many of the limitations associated with conventional, curved lens stacks.

Earlier in 2017, Spectrum Optix completed its proof-of-concept digital telescope prototype (POC). It uses a patent-pending Blade Optics™ technology, other optical elements, as well as electronic components. The intention of this prototype is to demonstrate the marketable features of Spectrum's Blade Optics™ technology and its potential to serve as a platform to be utilized in different optical applications.

This past June, NexOptic Technologyand Spectrum Optix announced that, further to their joint news release dated April 4, 2017, they have successfully completed the engineering trade study of a new telephoto lens stack design intended for mobile devices, including smartphones. Spectrum Optix filed a patent application with the United States Patent and Trademark Office (USPTO) related to its new design. Completion of the engineering trade study is the initial step in the Companies' plan to grow their optical technology pipeline.
Last month, NexOptic Technology and Spectrum Optix announced that NexOptic satisfied all of the cash expenditure requirements under its option to acquire 100 percent ownership interest of Spectrum Optix pursuant to the agreement between NexOptic, Spectrum, and Spectrum's shareholders dated October 22, 2015. NexOptic Technology further announced that its plan is to exercise its final option and complete the acquisition of Spectrum Optix on or about October 2017.

Upon completion of this Agreement, key management members of Spectrum Optix and NexOptic Technology will be appointed to the senior management and Board of Director positions of NexOptic Technology. NexOptic’s patent-pending optical technologies and lens stack designs are scalable to diverse sizes. They can be manufactured utilizing readily available optical materials.

NexOptic Technology Corp. (NXOPF), closed Monday's trading session at $0.90, down 2.49%, on 25,197 volume with 5 trades. The average volume for the last 60 days is 28,179 and the stock's 52-week low/high is $0.35/$2.84.

Liberated Syndication, Inc. (LSYN)

Promotion Stock Secrets reported earlier on Liberated Syndication, Inc. (LSYN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liberated Syndication, Inc. involves in the podcast hosting services business in the U.S. The Company formerly went by the name Webmayhem, Inc. It changed its corporate name to Liberated Syndication, Inc. in August 2016. Listed on the OTC Markets Group’s OTCQB, the Company is based in Pittsburgh, Pennsylvania.

Pertaining to its OnPublish – Multiple Destination Publishing, Liberated Syndication’s services provide independent podcasters tools to create a first-rate podcast and get that podcast into as many platforms as possible. Liberated Syndication is the largest leading podcast network. It provides podcast hosting services for producers of podcasting content; independent podcasters’ tools to publish content; as well as mobile apps (applications) for podcasts.

In addition, the Company offers advertisement insertion on certain of the producers’ content. Concerning Podcast Hosting Services, hosting is optimized for audio and video podcast distribution. The network is quick and reliable, and unmetered bandwidth and flexible storage space increases over time.

The Liberated Syndication publishing platform integrates content delivery to social media and blog platforms via the above-mentioned OnPublish, the Company’s Facebook App and HTML5 player. OnPublish incorporates publishing to Facebook, Twitter, WordPress and Blogger right from Liberated Syndication (Libsyn).

Concerning Mobile Apps for Podcast, the Libsyn custom smartphone app for podcasters involves audiences beyond one’s regular audio or video episodes. Four different types of content are accepted by the app (audio, video, PDF and text). All in one place, a user can offer their audience extras, blog posts, transcripts, and more.

Regarding MyLibsyn – Premium Content, it’s a complete subscription management service. The MyLibsyn offering includes a custom premium page and mobile apps available across four markets. One’s subscribers sign up and create one username and password. They can access their subscription across all available apps and one’s branded premium page.

Furthermore, the Company has its LibsynPRO – Enterprise Solutions. This is for professional media producers and corporate customers. LibsynPRO features podcast network tools. It is a turn-key podcast network solution. It allows for as many different shows and episodes as required. Additionally, effective reports convey sophisticated data on network, show, episode, device, as well as geographic performance.

Of note is that 35,000-plus podcasts have been hosted by the Company. It had 4.6 billion podcast downloads in 2016. Also, there are 62 million-plus monthly audience members, and Liberated Syndication has served the podcast community for more than 13 years.

The Company has cost effective plans to meet clients’ needs. It offers full service hosting to support a show’s growth and provides generous file storage and transfer policies.

Liberated Syndication, Inc. (LSYN), closed Monday's trading session at $1.11, up 2.78%, on 14,225 volume with 7 trades. The average volume for the last 60 days is 23,629 and the stock's 52-week low/high is $0.33/$1.15.

Sector 5, Inc. (SFIV)

The Street, YCharts, OTC Markets, 4-Traders, Marketwired, TradingView, and Capital Cube reported on Sector 5, Inc. (SFIV), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Sector 5, Inc. sells, manufactures, and develops new pioneering consumer electronics under Sector 5® and other brands. The OTCQB-listed Company, via its partnership with Google, is offering Chromebook eco-system products for educational organizations, through different B2B (Business-to-Business) and B2C (Business-to-Consumer) sales channels and through Amazon. Sector 5 has its corporate headquarters in Alexandria, Virginia.

The Company’s concentration is on providing e-learning products. It has developed new products integrating a seamless wireless charging experience serving the educational, business, and retail markets through easier bulk charging involving charging carts with built-in wireless transmitters.

Sector 5 announced, in December of 2016, the addition of its new E2 Chromebook, an HD convertible Chromebook with a touchscreen (1366 x 768 pixels), the Intel Braswell N3060 Processor, and also a tilting hinge to allow use in tablet and tent mode.

This newest Chromebook is equipped to serve well in schools, colleges, B2B, and more. The development of the E2 was to have a long-lasting battery for 10 hours of use on a single charge. It has 16-32GB eMMC flash storage and 11.6 inch IPS HD resolution display. There are three USB 3.0 ports, HDMI, a micro SD card slot, audio jack, stereo speakers, dual-band WiFi 802.11ac, as well as Bluetooth 4.0.

Sector 5 has its latest education product – the E2 Touchscreen. In addition, it has its 65" 4K DLED UHD TV, which is an Ultra Slim TV. The Company says this product is safe and efficient with an eye-catching display. Moreover, it is energy efficient. It features direct LED technology, is of a slim design, and includes a stand.

Fundamentally, Sector 5’s vision is to enable every K-12 child with an internet enabled Chromebook learning device. This encourages self growth and aids in eliminating poverty levels because of the lack of educational tools.

Sector 5’s education partnerships help the Company develop enrichment programs, which enhance distribution of Sector 5 learning devices. The Company provides user-friendly electronics to engage students anytime, anywhere.

Sector 5, Inc. (SFIV), closed Monday's trading session at $0.2247, even for the day. The average volume for the last 60 days is 3,664 and the stock's 52-week low/high is $0.20/$5.00.

graphic

The QualityStocks
Company Corner

graphic
graphic

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.0996, up 8.26%, on 11,500 volume with 4 trades. The stock’s average daily volume over the past 60 days is 40,430 and its 52-week low/high is $0.0711/$0.22.

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

Tapinator, Inc. (TAPM) is “One to Watch”

Tapinator Announces Q3 Preliminary Results and 2017 / 2018 Full-Year Guidance

Tapinator Announces Up to $3.0 Million Common Stock Capital Raise

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.565, off by 2.59%, on 87,282 volume with 82 trades. The stock’s average daily volume over the past 60 days is 104,295 and its 52-week low/high is $0.33/$2.75.

SeeThruEquity, the leading independent equity research firm focused on smallcap and microcap public companies, today announced it has issued an update note on ChineseInvestors.com, Inc. (OTCQB: CIIX). The report is available here: CIIX October 2017 Update Note.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

SeeThruEquity Issues Update on ChineseInvestors.com Inc. (OTCQB: CIIX)

ChineseInvestors.com, Inc. Appoints Skin Care Industry Veteran and Shanghai Beauty Influencer, Fannie Tang, as Marketing Director of its Wholly-owned Foreign Enterprise, CBD Biotechnology Co., Ltd.

ChineseInvestors.com, Inc. Announces Paul Dickman's Return as its Chief Financial Officer

LottoGopher Holdings Inc. (OTCQB:LTTGF) (CSE:LOTO) (FRA:2LG)

The QualityStocks Daily Newsletter would like to spotlight LottoGopher Holdings Inc. (LTTGF). Today, LottoGopher Holdings Inc. closed trading at $0.19, up 16.56%, on 249,527 volume with 63 trades. The stock’s average daily volume over the past 60 days is 101,344 and its 52-week low/high is $0.15/$0.50.

LottoGopher Holdings Inc. (LTTGF) is a new lottery messenger service that provides its subscribers with the security of ordering and managing the legal purchase of state lottery tickets online using debit and credit cards. LottoGopher makes it simple for users to keep track of tickets and winnings. Members have exclusive access to strategies, alerts, lottery news and can play alone with a single ticket or join online public or private groups to pool winnings.

LottoGopher is transforming the lottery buying experience, which has historically meant taking the time and spending the gas money to drive to a retail location, then stand in line to buy via cash only and redeem tickets. LottoGopher's uniquely online messenger service streamlines the experience of taking a shot at the lottery and makes it much more convenient and access to electronic payment, otherwise not permitted in CA. While only California residents at this time can play Mega Millions, SuperLotto Plus and Powerball through LottoGopher.com, expansion plans are in the works to allow internet-savvy residents in 22 other states with legal lotteries to have the same advantages of purchasing tickets online.

LottoGopher also enjoys a strategic business relationship with Lottoland, ranked in the Financial Times' FT1000 Report as one of Britain's Top 30 fastest growing companies and as the second ranked gaming company in Europe. Since launching in 2013, Lottoland has rapidly become a world leader in the online lottery sector with nearly $357 million (U.S. dollars) in annual sales.

LottoGopher's currently integrated support systems include a mobile friendly platform; automated email follow-up system to capture, score and remarket to email address leads; social media listening and outreach; utilization of Google Analytics tools; one-time promotional offers across multiple platforms; main and backup credit card processing accounts; and focus on customer service.

Customers of LottoGopher pay a subscription fee to use the service, much like Netflix, Amazon Prime or Dollar Shave Club. After selecting their subscription plan, users pay the same price per ticket as if purchasing from a retail, brick-and-mortar location. LottoGopher's team then secures the selected tickets from a lottery retailer partner. User account balances are updated after a drawing, which makes it impossible for a member to "lose" a winning ticket.

The company's target market includes the 80 million U.S. consumers already buying lottery tickets who typically purchase products online. Offering a far more convenient way to play the lottery via an intuitive platform, LottoGopher is well positioned to disrupt this multi-billion dollar industry. Disclaimer

LottoGopher Holdings Inc. Blog

LottoGopher Holdings Inc. News:

NetworkNewsWire Announces Publication Harnessing the Power of Celebrity Endorsements

NetworkNewsWire Releases Exclusive Audio Interview with LottoGopher Holdings Inc.

NetworkNewsWire Announces Publication on Successful Subscription Businesses

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $0.968, up 5.55%, on 1,206,316 volume with 514 trades. The stock’s average daily volume over the past 60 days is 175,644 and its 52-week low/high is $0.6171/$0.963.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

NetworkNewsWire Announces Publication Highlighting Public Companies Set to Reap the Rewards of the Cannabis Sector's Continuous Growth

NetworkNewsWire Announces Publication Discussing How Licensed Canadian Cannabis Producers are Preparing for Industry Forecasts

NetworkNewsWire Announces Publication on Investment Opportunities in Canada's Cannabis Market

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $0.93, up 3.33%, on 21,204 volume with 24 trades. The stock’s average daily volume over the past 60 days is 2,045, and its 52-week low/high is $0.74/$5.45.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO, Inc. (EVIO) is “One to Watch”

EVIO Labs to Provide Accredited Industrial Hemp Testing in Oregon

EVIO, Inc. (EVIO) Engages NetworkNewsWire for Corporate Communications Solutions

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(CLNT) +96.39%

2.

MarketClub Analysis
(HMNY) +33.90%

3.

PoliticsAndMyPortfolio
(PGTK) +30.95%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251